lmmol · Reviews

SNARE-Mediated Membrane Fusion and Neurotransmitter Release: Assembly, Triggering, and Disease

lmmol AI Research Collective · Published 2026-06-25 · lmmol:review:snare

🧪 lmctl-orchestrated review — written by an orchestrated team of AI agents, grounded in 540 papers from lmmol's literature graph. Citations link to their source on PubMed.

Key proteins at a glance
ProteinPapers
Syntaxin-1A34
Synaptosomal-associated protein 2529
Synaptosomal-associated protein 2322
Synaptosomal-associated protein 2519
Vesicle-trafficking protein SEC22b19
Synaptosomal-associated protein 2518
Syntaxin-717
Syntaxin-417

1. Overview

Fast chemical neurotransmission depends on the regulated fusion of synaptic vesicles with the presynaptic plasma membrane, a reaction catalyzed by a conserved set of SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) proteins. The foundational insight that the N-ethylmaleimide-sensitive fusion protein (NSF) and soluble NSF attachment proteins (SNAPs) bind membrane receptors termed SNAREs, with one partner residing on the synaptic vesicle and another on the target plasma membrane, established a unifying framework for vesicle docking and fusion across both constitutive and regulated pathways including neurotransmitter release [1]. The core neuronal machinery comprises the plasma-membrane t-SNAREs syntaxin-1A and SNAP-25 together with the vesicular v-SNARE synaptobrevin/VAMP2, whose assembly into a tight complex is thought to drive bilayer merger [1]. This review treats the fusion apparatus as an integrated system, tracing SNARE complex assembly, membrane fusion, and Ca2+-triggered synchronous release, with emphasis on recent structural, regulatory, and disease-related advances.

2. The SNARE machinery

SNARE zippering pulls vesicle and plasma membranes togetherv-SNARE VAMP2/R plus t-SNARE syntaxin-1A/SNAP-25/Q zipper N to CPRIMED / CLAMPEDhalf-zippered; complexin and synaptotagmin-1 clampVAMP2v-SNARE / R-SNARE on vesiclesyntaxin-1A + SNAP-25t-SNARE Q-SNAREs; SNAP-25 x2 helixcomplexin + syt-1clamp half-zippered bundleCa2+parallel four-helix bundle startsFULL ZIPPERING / FUSIONCa2+ releases clamp; C-terminal closure fuses bilayersCa2+ binds syt-1unlocks clamp4-helix SNARE bundleN->C zip; R/Q ionic layer at centerFUSIONbilayers merge; pore openspermits zipperingpulls membranes togetherTOXIN BLOCKZn2+ endopeptidases cleave individual SNAREsTeNT / BoNT-Bcut VAMP2BoNT-A / Ecut SNAP-25BoNT-C1cuts syntaxin
Ca2+-triggered SNARE zippering drives synaptic-vesicle fusion. The vesicular v-SNARE synaptobrevin/VAMP2 (R-SNARE) pairs with the plasma-membrane t-SNAREs syntaxin-1A and SNAP-25 (Q-SNAREs) into a parallel four-helix bundle. In the primed state complexin and synaptotagmin-1 clamp a half-zippered complex; Ca2+ binding to synaptotagmin-1 releases the clamp and permits full N-to-C zippering, whose energy pulls the two bilayers together to fuse. Clostridial neurotoxins (BoNT/TeNT) are Zn2+ endopeptidases that cleave individual SNAREs to block release.

The three neuronal SNAREs were each identified through distinct routes. Syntaxin (originally p35/HPC-1) was found as a nervous-system-specific plasma-membrane protein that interacts with synaptotagmin (p65) and immunoprecipitates N-type Ca2+ channels, suggesting a role in docking synaptic vesicles near Ca2+ channels at presynaptic active zones [2]. Syntaxin-1A belongs to a broader family of carboxy-terminally anchored transport receptors with distinct subcellular targeting, supporting the idea that each membrane compartment is marked by a specific syntaxin isoform [3]. SNAP-25 was cloned as a neuronal 25-kD synaptosomal protein lacking a transmembrane domain but bearing a cluster of cysteines and an amphipathic amino terminus that promote membrane association [4]. The vesicular partner VAMP-1 was characterized as a synaptic-vesicle integral membrane protein with a cytoplasmic-facing domain implicated in neurotransmitter release [5], and the ubiquitous homolog cellubrevin extended the synaptobrevin family to constitutively recycling pathways, underscoring shared fusion machinery between regulated and constitutive trafficking [6]. Assembly of these components is chaperoned by Sec1/Munc18-family (SM) proteins: the crystal structure of neuronal Sec1 bound to syntaxin-1A revealed a large conformational rearrangement of syntaxin relative to its state in the SNARE complex, indicating a regulated transition from a closed, SM-bound conformation toward core-complex formation [7].

3. Recent advances

Recent work has reframed SNARE assembly as a regulated, chaperoned, and disease-relevant process rather than a spontaneous one. A defining advance is the structure of the primed pre-fusion SNARE-complexin-synaptotagmin-1 complex, which revealed an unexpected tripartite interface in which synaptotagmin-1 contacts both the SNARE complex and complexin, while a second synaptotagmin-1 molecule engages the SNARE complex through a previously identified primary interface; Ca2+ binding unlocks this primed assembly, permits full SNARE zippering, and triggers fusion, explaining how complexin and synaptotagmin cooperate to synchronize evoked release on a sub-millisecond timescale [8]. The roles of SM proteins have also been clarified: in C. elegans and mammalian neurons, a gain-of-function Munc18-1/UNC-18 mutation enhances acetylcholine release and partially bypasses the requirement for Munc13/UNC-13, acting antagonistically with the negative regulator Tomosyn/TOM-1, supporting a model in which Munc18 primes fusion by templating SNARE complex assembly downstream of Munc13 [9]. In cytotoxic lymphocytes, Munc18-2 was shown to drive the transition from syntaxin-11-mediated hemifusion to complete membrane merger, reinforcing the broader concept that SM proteins are part of the core fusion machinery [10].

Regulation by accessory and presynaptic proteins has expanded the system view. α-Synuclein, a presynaptic protein linked to neurodegeneration, binds synaptobrevin-2/VAMP2 directly and promotes SNARE complex assembly as a nonclassical chaperone; mice lacking synucleins show age-dependent neurological impairment and reduced SNARE assembly, suggesting synucleins sustain repeated assembly cycles during aging [11]. The proline-rich transmembrane protein PRRT2 was identified as a presynaptic SNARE-complex regulator that downregulates complex formation, with loss-of-function mutations producing paroxysmal kinesigenic dyskinesia in mice [12]. Ca2+ sensing beyond synaptotagmin-1 is also a recent theme: otoferlin, a C2-domain protein defective in human deafness, binds Ca2+ and interacts Ca2+-dependently with syntaxin-1 and SNAP-25, and appears to be the major Ca2+ sensor triggering fusion at the auditory inner-hair-cell ribbon synapse [13]. SNARE function is further specialized across secretory systems—syntaxin-1A controls biphasic exocytosis of the incretin GLP-1 in intestinal L cells [14] and governs insulin granule docking and replenishment via interactions with VAMP8 in β cells [15]—illustrating how the neuronal paradigm generalizes to regulated hormone secretion.

4. Structural & mechanistic insights

The structural core of fusion is the four-helix SNARE bundle. The 2.4-Å crystal structure of the synaptic complex of syntaxin-1A, synaptobrevin-II, and SNAP-25B revealed a highly twisted, parallel four-helix bundle stabilized by leucine-zipper layers and a central ionic layer of one arginine and three glutamine residues conserved across the SNARE family, with a grooved surface suited to binding regulatory factors [16]. Independent spin-label EPR analysis confirmed that the two SNAP-25 helices run parallel to each other and to the syntaxin helix, supporting the parallel four-stranded coiled-coil model [17]. The conserved glutamine (Q) and arginine (R) contributions to the ionic layer underpin the Q-/R-SNARE classification that organizes the family. Mechanistically, full C-terminal zippering of the bundle is the energetically critical step that draws the membranes together; this is consistent with the finding that Ca2+-dependent unlocking of the primed complex permits complete zippering and fusion [8].

5. Disease & therapeutic relevance

The synaptic SNAREs are the molecular targets of clostridial neurotoxins, among the most potent toxins known, which act as zinc-dependent endopeptidases. Tetanus and botulinum-B neurotoxins cleave synaptobrevin-2 at the Gln76-Phe77 bond, blocking release [18]; botulinum neurotoxin A cleaves SNAP-25 near its carboxy terminus [19]; and botulinum neurotoxin C1 cleaves syntaxin [20], establishing all three core SNAREs as toxin substrates. A newly identified serotype, BoNT/X, has the lowest sequence identity to known toxins, evades existing antisera, cleaves VAMP1/2/3 at a novel site, and uniquely also cleaves the non-canonical substrates VAMP4, VAMP5, and Ykt6, causing flaccid paralysis in mice [21]. The 1.35-Å structure of the BoNT/X light chain showed it shares the conserved BoNT fold yet has a more restricted, non-conserved catalytic pocket and cleaves VAMP1 with roughly tenfold higher efficiency than BoNT/B or tetanus toxin, providing a basis for inhibitor design and for engineering toxins with distinct SNARE specificity for therapeutic use [22].

Human genetic disorders directly implicate SNARE and SNARE-regulatory genes. De novo VAMP2 mutations clustered in the C-terminal SNARE motif cause a neurodevelopmental disorder with hypotonia, intellectual disability, and autistic features, and impair reconstituted vesicle fusion [23]. Recessive VAMP1 mutations cause a presynaptic congenital myasthenic syndrome with impaired neuromuscular transmission, recapitulated in VAMP1-deficient mice [24], and a synaptobrevin-1/SYB1 frameshift that elongates the intravesicular C-terminus causes a fatal congenital myasthenic syndrome by reducing depolarization-evoked exocytosis [25]. On the t-SNARE side, mutations in syntaxin-11 cause familial hemophagocytic lymphohistiocytosis type 4, linking defective lytic-granule exocytosis to immune dysregulation [26], consistent with the syntaxin-11/Munc18-2 fusion mechanism described above [10].

6. Open questions & gaps

Several areas remain thinly represented in the present evidence base. The mechanistic role of NSF/SNAP-mediated complex disassembly and recycling is implied by the original SNARE hypothesis [1] but is not directly addressed by recent structural work here. Munc13's catalytic role in opening syntaxin and templating assembly is inferred largely indirectly from genetic bypass experiments [9] rather than from direct structures in this corpus. The precise lipidic intermediates of fusion—hemifusion versus full pore opening—are touched on only for lymphocyte syntaxin-11 [10], leaving the neuronal fusion-pore transition underdetermined. How α-synuclein's chaperone function relates to its pathological aggregation in disease is not resolved by the assembly-promoting data alone [11]. Finally, the diversity of Ca2+ sensors—synaptotagmin-1 versus otoferlin at specialized synapses [13][8]—raises unanswered questions about how distinct synapses tune speed and fidelity of release, an area where the available substrate offers framing but limited mechanistic depth.

References

  1. Soellner T., Whiteheart S.W., Brunner M., Erdjument-Bromage H. et al. SNAP receptors implicated in vesicle targeting and fusion. Nature 1993. PubMed 2,720×
  2. Bennett M.K., Calakos N., Scheller R.H. Syntaxin: a synaptic protein implicated in docking of synaptic vesicles at presynaptic active zones. Science 1992. PubMed 1,116×
  3. Bennett M.K., Garcia-Arraras J.E., Elferink L.A., Peterson K.E. et al. The syntaxin family of vesicular transport receptors. Cell 1993. PubMed 610×
  4. Oyler G.A., Higgins G.A., Hart R.A., Battenberg E. et al. The identification of a novel synaptosomal-associated protein, SNAP-25, differentially expressed by neuronal subpopulations. J. Cell Biol 1989. PubMed 720×
  5. Trimble W.S., Cowen D.M., Scheller R.H. VAMP-1: a synaptic vesicle-associated integral membrane protein. Proc. Natl. Acad. Sci. U.S.A 1988. PubMed 499×
  6. McMahon H.T., Ushkaryov Y.A., Edelmann L., Link E. et al. Cellubrevin is a ubiquitous tetanus-toxin substrate homologous to a putative synaptic vesicle fusion protein. Nature 1993. PubMed 450×
  7. Misura K.M.S., Scheller R.H., Weis W.I. Three-dimensional structure of the neuronal-Sec1-syntaxin 1a complex. Nature 2000. PubMed 625×
  8. Zhou Q., Zhou P., Wang A.L., Wu D. et al. The primed SNARE-complexin-synaptotagmin complex for neuronal exocytosis. Nature 2017. PubMed 229×
  9. Park S., Bin N.R., Yu B., Wong R. et al. UNC-18 and Tomosyn Antagonistically Control Synaptic Vesicle Priming Downstream of UNC-13 in Caenorhabditis elegans. J. Neurosci 2017. PubMed 33×
  10. Spessott W.A., Sanmillan M.L., McCormick M.E., Kulkarni V.V. et al. SM protein Munc18-2 facilitates transition of Syntaxin 11-mediated lipid mixing to complete fusion for T-lymphocyte cytotoxicity. Proc. Natl. Acad. Sci. U.S.A 2017. PubMed 30×
  11. Burre J., Sharma M., Tsetsenis T., Buchman V. et al. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 2010. PubMed 1,449×
  12. Tan G.H., Liu Y.Y., Wang L., Li K. et al. PRRT2 deficiency induces paroxysmal kinesigenic dyskinesia by regulating synaptic transmission in cerebellum. Cell Res 2018. PubMed 86×
  13. Roux I., Safieddine S., Nouvian R., Grati M. et al. Otoferlin, defective in a human deafness form, is essential for exocytosis at the auditory ribbon synapse. Cell 2006. PubMed 545×
  14. Wheeler S.E., Stacey H.M., Nahaei Y., Hale S.J. et al. The SNARE protein syntaxin-1a Plays an essential role in biphasic exocytosis of the incretin hormone glucagon-like peptide 1. Diabetes 2017. PubMed 35×
  15. Liang T., Qin T., Xie L., Dolai S. et al. New Roles of Syntaxin-1A in Insulin Granule Exocytosis and Replenishment. J. Biol. Chem 2017. PubMed 30×
  16. Sutton R.B., Fasshauer D., Jahn R., Brunger A.T. Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 A resolution. Nature 1998. PubMed 1,935×
  17. Poirier M.A., Xiao W., Macosko J.C., Chan C. et al. The synaptic SNARE complex is a parallel four-stranded helical bundle. Nat. Struct. Biol 1998. PubMed 427×
  18. Schiavo G., Benfenati F., Poulain B., Rossetto O. et al. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 1992. PubMed 1,464×
  19. Blasi J., Chapman E.R., Link E., Binz T. et al. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 1993. PubMed 1,004×
  20. Blasi J., Chapman E.R., Yamasaki S., Binz T. et al. Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin. EMBO J 1993. PubMed 463×
  21. Zhang S., Masuyer G., Zhang J., Shen Y. et al. Identification and characterization of a novel botulinum neurotoxin. Nat. Commun 2017. PubMed 201×
  22. Masuyer G., Zhang S., Barkho S., Shen Y. et al. Structural characterisation of the catalytic domain of botulinum neurotoxin X - high activity and unique substrate specificity. Sci. Rep 2018. PubMed 37×
  23. Salpietro V., Malintan N.T., Llano-Rivas I., Spaeth C.G. et al. Mutations in the Neuronal Vesicular SNARE VAMP2 Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment. Am. J. Hum. Genet 2019. PubMed 97×
  24. Salpietro V., Lin W., Delle Vedove A., Storbeck M. et al. Homozygous mutations in VAMP1 cause a presynaptic congenital myasthenic syndrome. Ann. Neurol 2017. PubMed 42×
  25. Shen X.M., Scola R.H., Lorenzoni P.J., Kay C.S. et al. Novel synaptobrevin-1 mutation causes fatal congenital myasthenic syndrome. Ann. Clin. Transl. Neurol 2017. PubMed 33×
  26. zur Stadt U., Schmidt S., Kasper B., Beutel K. et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum. Mol. Genet 2005. PubMed 415×
A cross-family review spanning 225 proteins — see the key proteins above, or browse all lmmol reviews.